Haematologica. 2017;102(5):e187-e190.
BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors.
제1저자 변자민 · 교신저자 고영일
소속 (15)
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, Korea.
- Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea go01@snu.ac.kr.
- Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Seoul, Korea.
- Department of Internal Medicine, Inje University Busan Paik Hospital, Seoul, Korea.
- Department of Internal Medicine, Korea University School of Medicine Anam Hospital, Seoul, Korea.
- Divison of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, Korea.
- Division of Hematology-Oncology, Department of Internal Medicine, Chonbuk National University Hospital, Seoul, Korea.
- Department of Internal Medicine, Korea University School of Medicine, Seoul, Korea.
- Department of Hematology-Oncology, Kyungpook National University Hospital, Goyang, Korea.
- Hematologic-Oncology Clinic, Center for Specific Organs Cancer, National Cancer Center, Goyang, Korea.
- Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Korea.
- Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic University of Korea, Korea.
그 밖의 정보
- 출판 형태
- Letter, Research Support, Non-U.S. Gov't
- 저널
- Haematologica · eISSN 1592-8721
- 전자 출판
- 2017-01-12
- MeSH
- Age Factors · Aged · Aged, 80 and over · Antineoplastic Agents / therapeutic use · Antineoplastic Combined Chemotherapy Protocols / adverse effects / therapeutic use · Biomarkers, Tumor · Fusion Proteins, bcr-abl / antagonists & inhibitors / genetics · Humans · Kaplan-Meier Estimate · Middle Aged · Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy / genetics / mortality / pathology · Prognosis · Protein Kinase Inhibitors / therapeutic use · Treatment Outcome
- Substances
- Antineoplastic Agents · Biomarkers, Tumor · Protein Kinase Inhibitors · Fusion Proteins, bcr-abl
- 참고문헌
- 15편